Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes

Hepatology Research

Volumn 37, Issue SUPPL. 1, 2007, Pages

  Kramvis, Anna ^a   Kew, Michael C ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Epidemiology; Genotypes; Subgenotypes

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

AFRICA; CAUSE OF DEATH; CONFERENCE PAPER; CORRELATION ANALYSIS; ENDEMIC DISEASE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH BEHAVIOR; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PHYLOGENY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; VERTICAL TRANSMISSION; VIRAL CONTAMINATION; VIRUS CARRIER; VIRUS DETECTION; VIRUS TRANSMISSION;

EID: 34447647679     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00098.x     Document Type: Conference Paper

References (91)

1. WHO. Hepatitis B vaccines. Wkly Epidemiol Rec 2004; 79: 255-63.
2. Kew MC. Chronic hepatitis B virus infection and hepatocellular carcinoma in Africa. S Afr J Sci 1992; 88: 524-8.
3. Kew MC. Hepatitis viruses and hepatocellular carcinoma. S Afr Med J 1994; 84: 550-6.
4. Martinson FE, Weigle KA, Mushahwar IK, Weber DJ, Royce R, Lemon SM. Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol 1996; 48: 278-83.
5. Bovet P, Yersin C, Herminie P, Lavanchy D, Frei PC. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bull World Health Organ 1999; 77: 923-8.
6. Amazigo UO, Chime AB. Hepatitis-B virus infection in rural and urban populations of eastern Nigeria: Prevalence of serological markers. East Afr Med J 1990; 67: 539-44.
7. Chiaramonte M, Stroffolini T, Ngatchu T et al. Hepatitis B virus infection in Cameroon: A seroepidemiological survey in city school children. J Med Virol 1991; 33: 95-9.
8. Pellizzer G, Ble C, Zamperetti N et al. Serological survey of hepatitis B infection in Tanzania. Public Health 1994; 108: 427-31.
9. Ndumbe PM, Atchou G, Biwole M, Lobe V, Ayuk-Takem J. Infections among pygmies in the Eastern Province of Cameroon. Med Microbiol Immunol (Berl) 1993; 182: 281-4.
10. el-Sayed HF, Abaza SM, Mehanna S, Winch PJ. The prevalence of hepatitis B and C infections among immigrants to a newly reclaimed area endemic for Schistosoma mansoni in Sinai, Egypt. Acta Trop 1997; 68: 229-37.
11. Sirisena ND, Njoku MO, Idoko JA et al. Carriage rate of hepatitis-B surface antigen (HBsAg) in an urban community in Jos, Plateau State, Nigeria. Niger Postgrad Med J 2002; 9: 7-10.
12. Vardas E, Mathai M, Blaauw D, McAnerney J, Coppin A, Sim J. Preimmunization epidemiology of hepatitis B virus infection in South African children. J Med Virol 1999; 58: 111-15.
13. Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: A pilot study. Am J Trop Med Hyg 1996; 54: 554-8.
14. Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 1993; 253: 197-201.
15. Triki H, Said N, Ben Salah A et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 1997; 91: 11-14.
16. Oshitani H, Kasolo F, Tembo C et al. Hepatitis B virus infection among pregnant women in Zambia. East Afr Med J 1995; 72: 813-15.
17. Tswana S, Chetsanga C, Nystrom L, Moyo S, Nzara M, Chieza L. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe. S Afr Med J 1996; 86: 72-5.
18. Aspinall S, Joubert JJ, Evans AC, Joseph S, Steele AD, Lecatsas G. Prevalence of hepatitis B in !Kung (San) children from Bushmanland, Namibia. Ann Trop Paediatr 1994; 14: 163-7.
19. Sall Diallo A, Sarr M, Fall Y, Diagne C, Kane MO. [Hepatitis B infection in infantile population of Senegal.] Dakar Med 2004; 49: 136-42 (in French).
20. Allain JP, Candotti D, Soldan K et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003; 101: 2419-25.
21. Matee MI, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 2006; 6: 21-26.
22. Kirk GD, Lesi OA, Mendy M et al. The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 2004; 39: 211-19.
23. Heikel J, Sekkat S, Bouqdir F et al. The prevalence of sexually transmitted pathogens in patients presenting to a Casablanca STD clinic. Eur J Epidemiol 1999; 15: 711-15.
24. Jacobs B, Mayaud P, Changalucha J et al. Sexual transmission of hepatitis B in Mwanza, Tanzania. Sex Transm Dis 1997; 24: 121-6.
25. Baba MM, Ajayi BB, Ekanem IA. Prevalence of hepatitis B surface antigen among patients suspected of liver diseases in a Nigerian hospital. Niger Postgrad Med J 2000; 7: 91-5.
26. Abdool Karim SS, Thejpal R, Coovadia HM. Household clustering and intra-household transmission patterns of hepatitis B virus infection in South Africa. Int J Epidemiol 1991; 20: 495-503.
27. Bile K, Mohamud O, Aden C et al. The risk for hepatitis A, B, and C at two institutions for children in Somalia with different socioeconomic conditions. Am J Trop Med Hyg 1992; 47: 357-64.
28. Tswana SA, Moyo SR. The interrelationship between HBV-markers and HIV antibodies in patients with hepatocellular carcinoma. J Med Virol 1992; 37: 161-4.
29. Abiodun PO, Olomu A, Okolo SN, Obasohan A, Freeman O. The prevalence of hepatitis Be antigen and anti-HBE in adults in Benin City. West Afr J Med 1994; 13: 171-4.
30. Hodges M, Sanders E, Aitken C. Seroprevalence of hepatitis markers; HAV, HBV, HCV and HEV amongst primary school children in Freetown, Sierra Leone. West Afr J Med 1998; 17: 36-7.
31. Abebe A, Nokes DJ, Dejene A, Enquselassie F, Messele T, Cutts FT. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect 2003; 131: 757-70.
32. Odaibo GN, Arotiba JT, Fasola AO, Obiechina AE, Olaleye OD, Ajagbe HA. Prevalence of hepatitis B virus surface antigen (HBsAg) in patients undergoing extraction at the University College Hospital, Ibadan. Afr J Med Med Sci 2003; 32: 243-5.
33. Jombo GT, Egah DZ, Banwat EB. Hepatitis B virus infection in a rural settlement of northern Nigeria. Niger J Med 2005; 14: 425-8.
34. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz 2005; 100: 13-16.
35. Kirk GD, Bah E, Montesano R. Molecular epidemiology of human liver cancer: Insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis 2006; 27: 2070-82.
36. Rapicetta M, Stroffolini T, Ngatchu T et al. Age- and sex-related study of HBV-DNA in HBsAg asymptomatic children from an endemic area (Cameroon). Ann Trop Paediatr 1991; 11: 325-9.
37. Kurbanov F, Tanaka Y, Fujiwara K et al. A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J Gen Virol 2005; 86: 2047-56.
38. Fujiwara K, Tanaka Y, Orito E et al. Distribution of HBV genotypes among HBV carriers in Benin: Phylogenetic analysis and virological characteristics of HBV genotype E. World J Gastroenterol 2005; 11: 6410-15.
39. Pawlotsky JM, Belec L, Gresenguet G et al. High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. J Med Virol 1995; 46: 269-72.
40. Harry TO, Bajani MD, Moses AE. Hepatitis B virus infection among blood donors and pregnant women in Maiduguri, Nigeria. East Afr Med J 1994; 71: 596-7.
41. Otegbayo JA, Fasola FA, Abja A. Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria. Trop Gastroenterol 2003; 24: 196-7.
42. Ojo OS, Thursz M, Thomas HC et al. Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver disease. East Afr Med J 1995; 72: 719-21.
43. Lodenyo H, Schoub B, Ally R, Kairu S, Segal I. Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg. East Afr Med J 2000; 77: 13-15.
44. Acquaye JK, Mingle JA. Hepatitis B viral markers in Ghanaian pregnant women. West Afr J Med 1994; 13: 134-7.
45. Damale NK, Lassey AT, Bekoe V. Hepatitis B virus seroprevalence among parturients in Accra, Ghana. Int J Gynaecol Obstet 2005; 90: 240-1.
46. Madzime S, Adem M, Mahomed K, Woelk GB, Mudzamiri S, Williams MA. Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. Cent Afr J Med 1999; 45: 195-8.
47. Guidozzi F, Schoub BD, Johnson S, Song E. Should pregnant urban south African women be screened for hepatitis B? S Afr Med J 1993; 83: 103-5.
48. Roingeard P, Diouf A, Sankale JL et al. Perinatal transmission of hepatitis B virus in Senegal, west Africa. Viral Immunol 1993; 6: 65-73.
49. Menendez C, Sanchez-Tapias JM, Kahigwa E et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999; 58: 215-20.
50. Oshitani H, Kasolo FC, Mpabalwani M et al. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Trans R Soc Trop Med Hyg 1996; 90: 235-6.
51. Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: A view from tropical and subtropical Africa. Gut 1996; 38 (Suppl 2): S5-12.
52. Okoth FA, Kobayashi M, Kaptich DC et al. Seroepidemiological study for HBV markers and anti-delta in Kenya. East Afr Med J 1991; 68: 515-25.
53. Yamanaka T, Takayanagi N, Nakao T, Kobayashi M, Baba K. [Seroepidemiological study of hepatitis B virus (HBV) infection in the rural community in Kenya - changing pattern of transmission model of HBV in Kenya.] Kansenshogaku Zasshi 1991; 65: 26-34 (in Japanese).
54. Dumpis U, Holmes EC, Mendy M et al. Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol 2001; 35: 99-104.
55. Bhimma R, Coovadia HM, Kramvis A, Adhikari M, Kew MC, Connolly CA. HBV and proteinuria in relatives and contacts of children with hepatitis B virus-associated membranous nephropathy. Kidney Int 1999; 55: 2440-9.
56. Cobelens FG, van Schothorst HJ, Wertheim-Van Dillen PM, Ligthelm RJ, Paul-Steenstra IS, van Thiel PP. Epidemiology of hepatitis B infection among expatriates in Nigeria. Clin Infect Dis 2004; 38: 370-6.
57. Vall Mayans M, Hall AJ, Inskip HM et al. Risk factors for transmission of hepatitis B virus to Gambian children. Lancet 1990; 336: 1107-9.
58. Vall Mayans M, Hall AJ, Inskip HM. Do bedbugs transmit hepatitis B? Lancet 1994; 344: 962.
59. Martinson FE, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol 1998; 147: 478-87.
60. McCarthy MC, el-Tigani A, Khalid IO, Hyams KC. Hepatitis B and C in Juba, southern Sudan: Results of a serosurvey. Trans R Soc Trop Med Hyg 1994; 88: 534-6.
61. Sidibe S, Sacko BY, Traore I. [Prevalence of serologic markers of the hepatitis B virus in pregnant women of Bamako, Mali.] Bull Soc Pathol Exot 2001; 94: 339-41 (in French).
62. Pido B, Kagimu M. Prevalence of hepatitis B virus (HBV) infection among Makerere University medical students. Afr Health Sci 2005; 5: 93-8.
63. Belo AC. Prevalence of hepatitis B virus markers in surgeons in Lagos, Nigeria. East Afr Med J 2000; 77: 283-5.
64. Norder H, Courouce AM, Coursaget P et al. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47: 289-309.
65. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine 2005; 23: 2409-23.
66. Olinger CM, Venard V, Njayou M et al. Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. J Gen Virol 2006; 87: 1163-73.
67. Owiredu WK, Kramvis A, Kew MC. Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D. J Med Virol 2001; 64: 441-54.
68. Hannoun C, Soderstrom A, Norkrans G, Lindh M. Phylogeny of African complete genomes reveals a West African genotype A subtype of hepatitis B virus and relatedness between Somali and Asian A1 sequences. J Gen Virol 2005; 86: 2163-7.
69. Mulders MN, Venard V, Njayou M et al. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 2004; 190: 400-8.
70. Kimbi GC, Kramvis A, Kew MC. Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa. J Gen Virol 2004; 85: 1211-20.
71. Kramvis A, Kew MC. Molecular characterization of subgenotype A1 (subgroup Aa) of hepatitis B virus. Hepatol Res 2007; 37: S27-S32.
72. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus - large-scale analysis using a new genotyping method. J Infect Dis 1997; 175: 1285-93.
73. Westland C, Delaney W, Yang H et al. Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1. Gastroenterology 2003; 125: 107-16.
74. Kato H, Gish RG, Bzowej N et al. Eight genotypes (A-H) of hepatitis B virus infecting patients from San Francisco and their demographic, clinical, and virological characteristics. J Med Virol 2004; 73: 516-21.
75. Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994; 198: 489-503.
76. Kramvis A, Restorp K, Norder H, Botha JF, Magnius LO, Kew MC. Full genome analysis of hepatitis B virus genotype E strains from South-Western Africa and Madagascar reveals low genetic variability. J Med Virol 2005; 77: 47-52.
77. Odemuyiwa SO, Mulders MN, Oyedele OI et al. Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa. J Med Virol 2001; 65: 463-9.
78. Suzuki S, Sugauchi F, Orito E et al. Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the Cote d'Ivoire: Complete genome sequence and phylogenetic relatedness of HBV genotype E. J Med Virol 2003; 69: 459-65.
79. Quintero A, Martinez D, Alarcon De Noya B et al. Molecular epidemiology of hepatitis B virus in Afro-Venezuelan populations. Arch Virol 2002; 147: 1829-36.
80. Chu CJ, Keeffe EB, Han SH et al. Hepatitis B virus genotypes in the United States: Results of a nationwide study. Gastroenterology 2003; 125: 444-51.
81. Kao JH. Hepatitis B viral genotypes: Clinical relevance and molecular characteristics. J Gastroenterol Hepatol 2002; 17: 643-50.
82. Kramvis A, Kew MC. Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat 2005; 12: 456-64.
83. Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-Saharan Africans. J Med Virol 2005; 75: 513-21.
84. Tanaka Y, Hasegawa I, Kato T et al. A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 2004; 40: 747-55.
85. Bahri O, Cheikh I, Hajji N et al. Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. J Med Virol 2006; 78: 353-7.
86. Bjornsdottir TB, Stanzeit B, Sallberg M, Love A, Hultgren C. Changing prevalence of hepatitis B virus genotypes in Iceland. J Med Virol 2005; 77: 481-5.
87. Ganne-Carrie N, Williams V, Kaddouri H et al. Significance of hepatitis B virus genotypes A to E in a cohort of patients with chronic hepatitis B in the Seine Saint Denis District of Paris (France). J Med Virol 2006; 78: 335-40.
88. Dal Molin G, Poli A, Croce LS et al. Hepatitis B virus genotypes, core promoter variants, and precore stop codon variants in patients infected chronically in North-Eastern Italy. J Med Virol 2006; 78: 734-40.
89. Echevarria JM, Avellon A, Magnius LO. Molecular epidemiology of hepatitis B virus in Spain: Identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol 2005; 76: 176-84.
90. Sallam TA, William Tong CY. African links and hepatitis B virus genotypes in the Republic of Yemen. J Med Virol 2004; 73: 23-8.
91. Motta-Castro AR, Martins RM, Yoshida CF et al. Hepatitis B virus infection in isolated Afro-Brazilian communities. J Med Virol 2005; 77: 188-93.